Cynosure Partners with LaserAway To Bring Potenza RF Microneedling System Nationwide

Cynosure Potenza RF microneedling system
Potenza is the world’s first, four-mode radio frequency (RF) microneedling device.
Photo courtesy of Cynosure

Cynosure has announced a partnership with LaserAway to significantly expand access to Cynosure’s Potenza RF Microneedling system at all their locations nationwide. This partnership enables LaserAway to provide best-in-class RF microneedling options to hundreds of thousands of patients across the United States.

Related: Hand & Stone Adds Dermalogica Pro Pen and Clear Start Products to Treatment Offerings

Potenza is the world’s first, four-mode radio frequency (RF) microneedling device, providing clinicians with versatility and even more customized options for patients setting a new standard in RF microneedling technology.

At the core of Potenza is its microneedling treatment, delivering both shallow and deep treatments using ultrafine needles combined with radiofrequency (RF) energy to penetrate the skin. This process triggers the body's natural healing response, stimulating collagen and elastin production for tighter and firmer skin through soft-tissue coagulation. The elastin and collagen building typically takes place four to six weeks after treatment, with optimal results usually seen 12 weeks after the last treatment.

"The expansion of this partnership with LaserAway signifies a leap forward in redefining accessible, anti-aging aesthetic treatments,” said Nadav Tomer, CEO of Cynosure. “We are honored and excited to have this partnership move to the next level. Potenza is designed to be exceptionally flexible; catering to all skin types, anywhere on the body at any time of year.”

"LaserAway is committed to offering our clients the latest advancements in aesthetics and offering Potenza fulfills that promise,” said Scott Heckman, CEO of LaserAway. “Cynosure is aligned with our passion for innovation and providing unmatched solutions that meet the evolving needs of our clients."

More in News